China Cord Blood Corporation (CO)
China Cord Blood Corporation Profit Margin: 41.64%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CO Profit Margin Rankings
| Overall | 97th percentile | 118 of 4391 |
| Sector | 97th percentile | 11 of 469 in Healthcare |
| Industry | 96th percentile | 1 of 25 in Medical Laboratories & Research |
CO Profit Margin Range, Past 5 Years
| Minimum | -9.41% | Mar 2010 |
| Maximum | 45.76% | Jun 2011 |
| Average | 26.65% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatility. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
You may also be interested in these CO related companies
CO News
China Cord Blood Corporation Announces Completion of $65 Million Convertible Debt Financing with KKR
Apr 27, 1:40PM PR Newswire
Apr 27, 1:40PM PR Newswire
$CO China Cordblood @ sub $3 gets a $65M KKR investment.. Will move big in time.
about 34 days ago by mentholatum
about 34 days ago by mentholatum
$CO Could really move up on recent news and t above avg volume it looks like it is about to accumulate
about 45 days ago by buylowsellhigh3
about 45 days ago by buylowsellhigh3
$FREE next FREE will be $CO. No debt, PE 9, and KKR, (USA Investment Co) is investing $65M in this Chinese company, Look at news today.
about 46 days ago by mentholatum
about 46 days ago by mentholatum
@EPS_MomentuM $CO I am excited and can"t wait. I just know how these things go.
about 46 days ago by buylowsellhigh3
about 46 days ago by buylowsellhigh3
Chinese going Gangbusters again: watch these three for morning gap up potential: $SGOC $LIWA $CO
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
$CO let the intraday traders get out.. Then grab. May be next week but this will be played. Another $FREE here..
about 46 days ago by mentholatum
about 46 days ago by mentholatum
@mentholatum $CO It will be. If the market is high tomorrow, it could get to $5. Regardless, I am looking for $3.50 in t NEAR future.
about 46 days ago by buylowsellhigh3
about 46 days ago by buylowsellhigh3
$CO but look at PE. Debt, Earnings, Insiders, and any negative you look for in a stock.. It ain't there. This one should be $7 right now.
about 46 days ago by mentholatum
about 46 days ago by mentholatum
$CO has its biggest Volume day since Nov. 5, 2010 when it broke 4M http://stks.co/3KAp
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
@EPS_MomentuM $FREE not exactly. I do, however, like your $CO idea. I am going to hold overnight bc I think it has HUGE potential.
about 46 days ago by buylowsellhigh3
about 46 days ago by buylowsellhigh3
Funniest thing, did $FREE get $65M investment or was it given to $CO by mistake instead. Cause Price movements are not justified in either.
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
$CO massive shorting today? because its daily average volume is extremely low, therefore there can't be this much vol. on buyers alone.
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
Healthcare Costs Surging in China, Hedge Fund makes huge $65M investment in $CO http://stks.co/3JuQ
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
$CHN $EDC $FXI $CO China soft landing predicted this qtr, with a strong rebound in 2nd half 2012. http://stks.co/3JrS
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
$CO should get a lot more Money Inflow now that "KKR invests $65 mln" in China Cord Blood Corp.at MarketWatch (Thu 9:36AM EDT)
about 46 days ago by EPS_MomentuM
about 46 days ago by EPS_MomentuM
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2012 Financial Results
Feb 21, 5:00AM PR Newswire
Feb 21, 5:00AM PR Newswire
China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
Dec 19, 4:00PM PR Newswire
Dec 19, 4:00PM PR Newswire
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2012
Nov 28, 4:00PM PR Newswire
Nov 28, 4:00PM PR Newswire
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
Nov 18, 5:00AM PR Newswire
Nov 18, 5:00AM PR Newswire
China Cord Blood, Tessera Technologies: Biggest Price Gainers (CO, TSRA)
Nov 16, 12:46PM The Wall Street Journal
Nov 16, 12:46PM The Wall Street Journal
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CO | 2.63 | -0.04 | -1.50% | 193.17M |
| CNYD | 0.92 | +0.04 | +4.55% | 17.99M |
| CNX | 29.59 | +0.02 | +0.07% | 6.733B |
| CNW | 33.65 | -0.29 | -0.85% | 1.877B |
| CNU | 6.45 | +0.00 | +0.00% | |
| CNTY | 2.95 | -0.05 | -1.67% | 70.45M |
| CNTF | 1.01 | +0.03 | +3.05% | 53.46M |
| CNSL | 14.14 | +0.19 | +1.36% | 422.36M |
| CMRE | 13.56 | +0.25 | +1.88% | 817.67M |
| CMP | 72.79 | -0.77 | -1.05% | 2.404B |